OCULAR THERAPEUTIX INC (OCUL) Stock Cash Flow
NASDAQ:OCUL - Nasdaq - US67576A1007 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -192.71M | -193.51M | -80.74M | -71.04M | -6.55M | |||
| Depreciation Amortization | 3.85M | 3.79M | 2.98M | 2.11M | 2.42M | |||
| Change In Working Capital | 8.31M | -10.23M | -7.41M | 1.35M | -2.90M | |||
| Interest Paid | 10.71M | 21.53M | 5.46M | 2.15M | 1.93M | |||
| Other non cash items | 35.09M | 65.27M | 14.93M | 7.98M | -58.52M | |||
| OPERATING CASH FLOW | -145.46M | -134.68M | -70.23M | -59.60M | -65.55M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.97M | -1.29M | -6.09M | -3.72M | -1.19M | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -2.97M | -1.29M | -6.09M | -3.72M | -1.19M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 56.35M | 0.00 | -450.00K | |||
| Stock Issued/Repurchased | 15.07M | 332.11M | 118.66M | 1.45M | 3.30M | |||
| Other Financing Activity | N/A | N/A | -5.18M | N/A | N/A | |||
| FINANCING CASH FLOW | 15.07M | 332.11M | 169.83M | 1.45M | 2.85M | |||
| CHANGE IN CASH | -133.36M | 196.15M | 93.51M | -61.87M | -63.89M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -145.46M | -134.68M | -70.23M | -59.60M | -65.55M | |||
| Capital Expenditure | -2.97M | -1.29M | -6.09M | -3.72M | -1.19M | |||
| FREE CASH FLOW | -148.43M | -135.97M | -76.32M | -63.32M | -66.74M | |||
All data in USD